(Q37031517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Srinivasan Madhusudan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Lucy Gossage

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

361-380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03256260

29 December 2019

exact match

0 references

cites work

Pharmacogenetic perspectives gained from twin and family studies

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Pharmacogenetics for individualized cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Cancer pharmacogenomics: international trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

The cellular response to general and programmed DNA double strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

DNA mismatch repair: molecular mechanisms and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Repair of DNA double strand breaks by non-homologous end joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Repair of abasic sites in DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

The eukaryotic nucleotide excision repair pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Role of DNA mismatch repair defects in the pathogenesis of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

PARP-1, a determinant of cell survival in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

21 January 2018

PARP goes transcription

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Genome maintenance mechanisms for preventing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

The mechanics of base excision repair, and its relationship to aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Effects of base excision repair gene polymorphisms on pancreatic cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Functional characterization of Ape1 variants identified in the human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Subpathways of nucleotide excision repair and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Molecular mechanisms of mammalian global genome nucleotide excision repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Affinity purification and characterization of human O6-alkylguanine-DNA alkyltransferase complexed with BCNU-treated, synthetic oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

A convenient method for genotyping of human O6-methylguanine-DNA methyltransferase polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

A polymorphism at codon 160 of human O6 methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Reaction of O6-benzylguanine-resistant mutants of human O6-alkylguanine-DNA alkyltransferase with O6-benzylguanine in oligodeoxyribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Role of codon 160 in the sensitivity of human O6-alkylguanine-DNA alkyltransferase to O6-benzylguanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Quantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

DNA double-strand breaks: signaling, repair and the cancer connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Differential usage of non-homologous end-joining and homologous recombination in double strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

DNA double-strand break repair: all's well that ends well

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Coding variants in human double-strand break DNA repair genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Improved survival in women with BRCA-associated ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

In search of the tumour-suppressor functions of BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

The role of BRCA1 in the cellular response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

BRCA1, a potential predictive biomarker in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Radiosensitivity of human fibroblasts is associated with amino acid substitution variants in susceptible genes and correlates with the number of risk alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Genetic predictors of adverse radiotherapy effects: the Gene-PARE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Predominance of null mutations in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Functional consequences of ATM sequence variants for chromosomal radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256260

DNA double-strand break repair by homologous recombination

21 January 2018

1 reference

12 December 2020

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy

1 reference

12 December 2020

Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma

1 reference

12 December 2020

Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients

1 reference

12 December 2020

ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.

1 reference

12 December 2020

Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes

1 reference

12 December 2020

Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene

1 reference

12 December 2020

Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer

1 reference

12 December 2020

Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients

1 reference

12 December 2020

Lack of association between Caucasian lung cancer risk and O6-methylguanine-DNA methyltransferase-codon 178 genetic polymorphism

1 reference

12 December 2020

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer

1 reference

12 December 2020

Repair of synthetic oligonucleotides containing O6-methylguanine, O6-ethylguanine and O4-methylthymine, by O6-alkylguanine-DNA alkyltransferase.

1 reference

12 December 2020

Molecular modeling of O6-methylguanine-DNA methyltransferase mutant proteins encoded by single nucleotide polymorphisms.

1 reference

12 December 2020

Poly(ADP-ribose) polymerase in base excision repair: always engaged, but not essential for DNA damage processing.

1 reference

12 December 2020

A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy

1 reference

12 December 2020

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity

1 reference

12 December 2020

Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells

1 reference

12 December 2020

[Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer]

1 reference

12 December 2020

Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy

1 reference

12 December 2020

Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans

1 reference

12 December 2020

Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity

1 reference

12 December 2020

Resistance of the human O6-alkylguanine-DNA alkyltransferase containing arginine at codon 160 to inactivation by O6-benzylguanine.

1 reference

12 December 2020

Radiosensitivity of cervical cancer cell lines: the impact of polymorphisms in DNA repair genes

1 reference

12 December 2020

Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.

1 reference

12 December 2020

Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient

1 reference

12 December 2020

Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?

1 reference

12 December 2020

Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype

1 reference

12 December 2020

Pharmacogenomics: marshalling the human genome to individualise drug therapy

1 reference

12 December 2020

Influence of genetic markers on survival in non-small cell lung cancer.

1 reference

12 December 2020

A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.

1 reference

12 December 2020

[Polymorphisms in nucleotide excision repair genes XPC and XPD and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer]

1 reference

12 December 2020

[Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy]

1 reference

12 December 2020

BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures

1 reference

12 December 2020

Influence of Polymorphisms in DNA Repair GenesXPD, XRCC1andMGMTon DNA Damage Induced by Gamma Radiation and its Repair in LymphocytesIn Vitro

1 reference

12 December 2020

A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer

1 reference

12 December 2020

Loss of DNA mismatch repair in acquired resistance to cisplatin

1 reference

12 December 2020

Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.

1 reference

12 December 2020

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Polymorphism in the human O6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis

1 reference

12 December 2020

Association of an ERCC1 polymorphism with adult-onset glioma.

1 reference

12 December 2020

XPD polymorphisms: effects on DNA repair proficiency

1 reference

12 December 2020

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

1 reference

12 December 2020

Mortality rates among carriers of ataxia-telangiectasia mutant alleles

1 reference

12 December 2020

Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18078354%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference